The Unani system of medicine, rooted in Greco-Arabic tradition, offers a unique perspective on the concept of immune balance, emphasizing the harmonious regulation of bodily humors (Akhlat), temperament (Mizaj), and vital faculties (Quwa). Contemporary research into immunomodulation underscores the relevance of Unani principles in understanding host defense mechanisms and susceptibility to disease. This review critically examines the Unani concepts of immune balance, correlates them with current immunological knowledge, highlights epidemiological trends, risk factors, diagnostic considerations, and assesses therapeutic strategies, including integration with modern immunotherapeutics. Special attention is given to emerging evidence, guideline recommendations, and the potential translational value of Unani insights in clinical practice.
The immune system's pivotal role in maintaining health and preventing disease has long been recognized by various traditional medical systems, including Unani medicine. Developed through centuries of Greco-Arabic scholarship, Unani medicine describes immunity as a dynamic equilibrium that preserves internal stability (homeostasis) and resists disease. The Unani paradigm integrates humoral theory, temperament, and the function of vital organs, positing that immune health (Quwwat-e-Mudabbira-e-Badan) is governed by the balance among four humors: blood (Dam), phlegm (Balgham), yellow bile (Safra), and black bile (Sauda). This review explores the scientific underpinnings and clinical implications of Unani concepts of immune balance in light of modern immunology and translational medicine.
Globally, immune-related disorders—including autoimmune diseases, allergies, and infections—contribute significantly to morbidity and mortality. According to the World Health Organization, immune dysfunctions represent an escalating burden due to population aging, environmental challenges, and changes in lifestyle. In South Asia and the Middle East—regions where Unani medicine maintains a substantial presence—chronic inflammatory diseases, metabolic syndromes, and emerging infections highlight the need for integrative approaches to immune modulation. The epidemiological relevance of immune balance, as conceptualized in Unani medicine, is underscored by the rising prevalence of non-communicable diseases and immune-mediated conditions.
In Unani theory, immune imbalance arises from derangements in the quality or quantity of humors, leading to altered temperament and impaired organ function. The Quwwat-e-Mudabbira-e-Badan, or the body's governing faculty, orchestrates defense mechanisms by regulating the interplay of humors, vital heat (Hararat-e-Ghareezia), and organ systems. Modern immunology parallels this by describing innate and adaptive immune responses, cytokine networks, and cellular homeostasis. Unani medicine's emphasis on temperament and organ vitality may correspond to immunometabolic regulation and stress response pathways identified in recent biomedical research. Disruption in these systems precipitates susceptibility to infection, inflammation, and degenerative processes.
Unani practitioners identify risk factors for immune imbalance including dietary indiscretions (Mizaj-al-Ma’kul wa Mashrub), environmental exposures, psychological stress, and hereditary predispositions. Contemporary evidence supports the immunomodulatory impacts of nutrition, circadian disruption, psychosocial stressors, and genetic polymorphisms. Specific Unani temperaments (e.g., Damwi or Safrawi) may be linked to higher risk profiles for inflammatory or immune-mediated disorders, inviting further investigation into phenotype-genotype correlations and personalized medicine approaches.
Clinically, immune imbalance in Unani medicine manifests as increased vulnerability to infections, recurrent inflammatory states, delayed wound healing, and chronic fatigue. Symptoms are interpreted through the lens of humor predominance or deficiency, with attention to systemic signs such as changes in skin, appetite, sleep, and organ function. Modern immunology recognizes parallel clinical spectra—ranging from immunodeficiency to autoimmunity—underscoring the need for integrated diagnostic and therapeutic frameworks.
Diagnostic methodology in Unani medicine is holistic, involving detailed history-taking, pulse and urine examination, assessment of temperament, and evaluation of physical signs. Recent advances recommend complementing these traditional techniques with laboratory immunological assays, biomarker profiling, and imaging studies to substantiate clinical impressions and monitor therapy. The Unani approach to diagnosis emphasizes early detection of imbalance, personalized evaluation, and prevention of disease progression.
Unani management of immune imbalance focuses on restoration of humor equilibrium through regimental therapies (Ilaj-bil-Tadbeer), dietary modifications (Ilaj-bil-Ghiza), pharmacotherapy (Ilaj-bil-Dawa), and surgical interventions where indicated. Herbal immunomodulators such as Withania somnifera (Ashwagandha), Glycyrrhiza glabra (Licorice), and Tinospora cordifolia have demonstrated immune-enhancing activity in vitro and in vivo. Adjunctive therapies include cupping (Hijama), massage, and hydrotherapy. Clinical integration with modern immunomodulatory drugs is being explored to optimize outcomes, minimize adverse effects, and improve patient adherence.
Recent research has validated several Unani herbal formulations for their immunomodulatory, anti-inflammatory, and antioxidant properties. Phytochemical studies have identified bioactive compounds—such as alkaloids, flavonoids, and glycosides—responsible for these effects. Emerging therapies leverage nanotechnology for targeted delivery of Unani bioactives, and molecular docking studies suggest synergistic potential with conventional immunotherapeutics. Clinical trials are underway to assess safety, efficacy, and immunological endpoints, aiming to establish robust evidence for mainstream integration.
National and international regulatory bodies advocate for the integration of evidence-based traditional medicine within comprehensive care models, especially in regions where Unani practice is prevalent. Guidelines recommend rigorous standardization of Unani formulations, pharmacovigilance, and interprofessional collaboration. Personalized assessment of temperament, humor status, and risk factors is emphasized, along with lifestyle counseling and patient education. Hybrid care models—combining Unani and biomedical approaches—are encouraged for refractory and chronic immune-related disorders.
The Unani concept of immune balance offers a sophisticated, mechanism-based framework that complements contemporary immunological science. Its emphasis on humoral regulation, temperament, and holistic care aligns with emerging paradigms in personalized and integrative medicine. Bridging traditional Unani wisdom with modern biomedical research holds promise for innovative, patient-centered strategies in immune modulation, prevention, and management. Future directions should focus on clinical validation, multidisciplinary collaboration, and translational research to maximize the clinical impact of Unani insights on immune health.
1.
Even when they are not paying attention, children are still learning.
2.
Study finds higher breast cancer rates in areas with more air pollution
3.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
4.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
5.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
1.
Case-Based Learning on Functional Bone Marrow Recovery Following Sequential Immune Challenges
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
4.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
5.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Understanding Cancer: Early Detection and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation